The Latest Breaking News from Kidney Transplant

Health bosses at Manchester University NHS Foundation in England, in the U.K., refused to give the young boy a transplant.

Jaxon Green, 6, was diagnosed with kidney disease the day he was born. His illness meant that for years his life would depend on daily dialysis. And because his family lives in Tamaqua, a rural Pennsylvania town, his diagnosis also meant taking frequent two-hour trips to Philadelphia to see the…

A Tokyo-based nonprofit organization called the Intractable Disease Patient Support Association is suspected of having facilitated a kidney transplant that used a trafficked organ from a living donor overseas. The Yomiuri Shimbun asked experts in the relevant legal and medical systems for their opinion on this matter. In this installment,…

Pediatric nephrology is a niche field — and specialists are not spread out evenly across the country

In a case of suspected organ trafficking in living donor kidney transplants, a nonprofit organization in Japan had planned transplants in Sri Lanka this year and told an overseas coordinator it would send "two patients [at intervals] for a total of about 10 patients," The Yomiuri Shimbun has learned from…

The price per kidney was 15,000, dollars the equivalent today of about 2 million yen. The kidney transplant for the Japanese patient was conducted in the Central Asian country of Kyrgyzstan. A Japanese nonprofit organization acted as an intermediary. A passport was forged for the Ukrainian donor to make it…

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

A family have released before and after pictures of a seriously ill mom in desperate need of a kidney transplant.

Three patients have undergone CAR T-cell therapy, which genetically alters their immune system to protect their organs

AlloVir Inc (NASDAQ:ALVR) announced preliminary, blinded data from an ongoing Phase 2 study of posoleucel for BK viremia (BKV) in adult kidney transplant recipients.  These data provide an early indication of the safety and tolerability profile of posoleucel in kidney transplant recipients with BK viremia, which is associated with reduced graft survival and…

Test your Science quotient with this quiz